Multibagger Pharma Penny Stock Under Rs 20 Hit Upper Circuit After Company Secures Rs 24.06 Crore Contract for Medicine Supply to Afghanistan
DSIJ Intelligence-2 / 29 Aug 2025/ Categories: Mindshare, Multibaggers, Penny Stocks, Trending

The stock gave multibagger return of 2,200 per cent in 3 years and a whopping 9,000 per cent in 5 years.
Shukra Pharmaceuticals Limited has been awarded a contract worth Rs 24.06 crore for the supply of medicines and diagnostic kits to Afghanistan. The contract was awarded by HSCC (India) Limited, a Government of India enterprise, on behalf of the Ministry of External Affairs, Government of India. The Letter of Award, dated August 28, 2025, also includes comprehensive services such as packing, forwarding, insurance, and delivery to the consignee site in Kabul, Afghanistan. The management of the company believes this contract will positively impact business growth, brand positioning, and stakeholder value.
About Company
Incorporated in 1993, Shukra Pharmaceuticals Ltd manufactures and markets pharmaceutical products, and does laboratory testing. SPL is a is WHO-GMP certified integrated manufacturer of formulations like tablet, capsules and small volume parenteral. It has assisted in the development and manufacture of a variety of drugs and dosage forms and potency variations for many pharmaceutical companies.
The company has a market cap of over Rs 1,100 crore with a 3-year stock price CAGR of 191 per cent.
The company reported positive results in both quarterly and annual financial statements. In Q1FY25, the company reported net sales of Rs 5.39 crore and net profit of Rs 1.03 crore. In FY25, the company did net sales of Rs 32.59 crore and net profit of Rs 9.58 per share.
DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, download the service details here.
According to the shareholding, the promoters own a 50.95 per cent stake in the company while DIIs own 0.11 per cent and the public owns 48.94 per cent as of March 2025. The stock gave multibagger return of 2,200 per cent in 3 years and a whopping 9,000 per cent in 5 years.
Disclaimer: The article is for informational purposes only and not investment advice.
